The pharmaceutical group Chemo opens two new plants in Spain which will produce injectable medicines07 / 06 / 2017
The pharmaceutical multinational Chemo Group has just announced that it is opening two new plants that will produce injectable medicines. With these new facilities, the company now has a total of six plants in this country, employing more than 1,600 people between all of its work centres.
The new plants, Universal Farma (Azuqueca de Henares, Guadalajara) with over 8,000 m2, and Farmalan (Villaquilambre, León) with 3,600 m2, have been prepared for the manufacture and final packaging of injectable medicines and are equipped with the sector’s latest technology. The start-up of both plants required an initial investment from the company of almost 30 million euros.
According to the Director of Chemo Group’s industrial division, Lucas Sigman, “the addition of these plants is part of the company’s growth strategy, which aims to cover all of the industry’s technology needs for the development of affordable high-quality medicines. Additionally, we are fully committed to Spain, so we maintain a strong and sustained investment effort and a clear commitment to the creation of jobs”.
The two new plants have a workforce of nearly 80 professionals who are experts in sterile injectables, mainly working in the areas of maintenance and safety, quality, production and R&D.
Cutting edge technologies
Specialised in the development and manufacture of injectable medicines, these plants provide a wide range of oil-based and water-based solutions, suspensions, lyophilised and hormonal products, with the plant in León being particularly notable for only manufacturing injectable hormonal medicines.